Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 12/20 | 0.94 |
| ▸ | P2RY4 | P51582 | 7/20 | 0.94 |
| ▸ | P2RY6 | Q15077 | 6/20 | 0.94 |
| ▸ | P2RY14 | Q15391 | 7/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uridine Triphosphate SCHEMBL12636116 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL2778525 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| SCHEMBL376210 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL76682 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL14976686 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL24414746 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL107380 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL14406726 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL12671699 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL29829840 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7511 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260117271-A1 | SPECTRAL MONITORING OF IN VITRO TRANSCRIPTION | SANOFI PASTEUR INC (US) | 2026-04-30 | — | — | US | claimed |
| US-20260028622-A1 | RNA NANOSTRUCTURES WITH BASE MODIFICATIONS FOR REDUCING INNATE IMMUNOGENICITY | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2026-01-29 | — | — | US | claimed |
| US-20250388944-A1 | IN VITRO TRANSCRIPTION TECHNOLOGIES | BioNTech SE (DE) | 2025-12-25 | — | — | US | claimed |
| US-20250378906-A1 | METHODS AND ARRANGEMENTS FOR INTERACTIVE SIMULATION OF XRNA PRODUCTION | ARRANTA BIO HOLDINGS LLC (US) | 2025-12-11 | — | — | US | claimed |
| US-20250369028-A1 | CONTINUOUS IN VITRO TRANSCRIPTION PROCESS AND APPARATUS | MODERNATX, INC. (US) | 2025-12-04 | — | — | US | claimed |
| US-12460259-B2 | Fed-batch in vitro transcription process | MODERNATX, INC. (US) | 2025-11-04 | — | — | US | claimed |
| US-20250277180-A1 | APPARATUS, SYSTEMS AND METHODS FOR CONTINUOUS RNA MANUFACTURING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2025-09-04 | — | — | US | claimed |
| EP-4599077-A1 | SPECTRAL MONITORING OF IN VITRO TRANSCRIPTION | Sanofi Pasteur Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| CN-120189502-A | Mycobacterium tuberculosis antigen combination, mRNA encoding the same and vaccine | 复旦大学 | 2025-06-24 | — | — | CN | claimed |
| US-5565327-A | DETECTING HYPERPHOSPHORYLATION OF KINASE SUBSTRATE | DUKE UNIVERSITY (US) | 1996-10-15 | — | — | US | claimed |
| US-5547835-A | USING THE SANGER SEQUENCING STRATEGY AND ASSEMBLING THE SEQUENCE INFORMATION BY ANALYSIS OF THE NESTED FRAGMENTS OBTAINED BY BASE-SPECIFIC CHAIN TERMINATION VIA THEIR DIFFERENT MOLECULAR MASSES | SEQUENOM, INC. (US) | 1996-08-20 | — | — | US | claimed |
| EP-0679196-A1 | DNA SEQUENCING BY MASS SPECTROMETRY | SEQUENOM, INC. (US) | 1995-11-02 | — | — | EP | claimed |
| WO-1995026136-A1 | PARASITE ENZYME INHIBITORS AND SUBSTRATE ANALOGS | DUKE UNIVERSITY (US) | 1995-10-05 | — | — | WO | claimed |
| WO-1994016101-A2 | DNA SEQUENCING BY MASS SPECTROMETRY | KOESTER HUBERT (US) | 1994-07-21 | — | — | WO | claimed |
| EP-0519053-A4 | NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES | — | 1993-03-31 | — | — | EP | claimed |
| EP-0519053-A1 | NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES. | PROMEGA CORP (US) | 1992-12-23 | — | — | EP | claimed |
| WO-1992012261-A1 | NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES | PROMEGA CORPORATION (US) | 1992-07-23 | — | — | WO | claimed |
| EP-0076647-A2 | Culture media for cells originating from the immune system | HANA Biologics Incorporated (US) | 1983-04-13 | — | — | EP | claimed |
| EP-0009076-B1 | METHOD FOR THE QUANTITATIVE ENZYMATIC DETERMINATION OF ADP AND REAGENT FOR THIS METHOD | Roche Diagnostics GmbH (DE) | 1981-07-29 | — | — | EP | claimed |